GSK announced positive headline results from five studies

LONDON, UK: GlaxoSmithKline plc announced positive headline results from five studies of the Phase 3 ASCEND programme, evaluating the efficacy and safety profile of daprodustat, an investigational oral hypoxia-inducible factor…

NNR July 16, 2021

London Exchange

GSK sets new environmental goals

Emma Walmsley, Chief Executive Officer, GSK, said, "As a global healthcare company, we want to play our full part in protecting and restoring the planet's health, in order to protect…

NNR November 3, 2020

London Exchange

GSK sells its holding in Hindustan Unilever Limited

LONDON: On 1 April 2020 GlaxoSmithKline plc (GSK) announced the completion of its divestment of Horlicks and other Consumer Healthcare nutrition products in India to Unilever, including the merger of…

NNR May 7, 2020